Article
Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation.
PloS one - 1 Jan 2020
Sultana Saki, Stewart Jacklyn, van der Spoel Aarnoud C
Abstract excerpt
The enzyme β-glucosidase 2 (GBA2) is clinically relevant because it is targeted by the drug miglustat (Zavesca®) and because it is involved in inherited diseases. Mutations in the GBA2 gene are associated with two neurological diseases on the ataxia-spasticity spectrum, hereditary spastic paraplegia 46 (SPG46) and Marinesco-Sjögren-like syndrome (MSS). To establish how GBA2 mutations give rise to neurological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
